ENCANTO Clinical Study Reaches an Important Milestone
The ENCANTO clinical study continues to make steady progress, marking an important milestone in the project’s implementation.
Following the enrolment of the first participant in August 2025, the first surgical procedure was successfully performed in October 2025. Since then, more than 20 patients have undergone treatment within the study and continue to be followed according to the clinical protocol.
To date, no serious adverse reactions have been reported among study participants. While these findings support the ongoing evaluation of the treatment’s safety, it is still too early to draw conclusions regarding its clinical efficacy. The study will continue to follow participants over the planned follow-up period, and the final analysis will be performed after all patient data have been collected.
Patient recruitment remains ongoing, and individuals interested in participating in the study are encouraged to contact one of the participating clinical centres listed on the For Patients section of the ENCANTO website to learn more about the eligibility criteria and enrolment process.